77 results
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
24 May 24
Avalon GloboCare Corp. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
5:10pm
) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative cell-based technology, cellular therapy and precision … GloboCare Corp.
Avalon GloboCare Corp. (NASDAQ: ALBT) is a commercial stage company dedicated to developing and delivering innovative, transformative
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
5 Sep 23
Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules
8:56am
) – Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory … and delivering innovative, transformative, precision diagnostics and clinical laboratory services. Avalon is establishing a leading role
8-K
EX-99.1
lov2mx31 3mfs767au
21 Aug 23
Avalon’s Laboratory Services MSO Announces Expansion into Arizona
9:11am
8-K
EX-99.1
872c6
24 Jul 23
Avalon’s Laboratory Services MSO Acquires Texas Lab with Significant Potential Growth
9:05am
8-K
EX-99.1
97r8d chl1kk
19 Jul 23
Regulation FD Disclosure
9:21am
424B3
21gvl2uxm ik4eyxntw
29 Jun 23
Prospectus supplement
4:31pm
8-K
EX-99.1
gf5ryc845 vjzisvvcp
16 Jun 23
Entry into a Material Definitive Agreement
4:08pm
8-K
zprtewp
16 Jun 23
Entry into a Material Definitive Agreement
4:08pm
8-K
EX-99.1
2hit06wuo
27 Apr 23
Avalon GloboCare Reports Laboratory Services MSO Revenue of $14.7 Million and Net Income of $6.3 Million in 2022
4:26pm
8-K
EX-99.1
0ils0wf6b61
14 Dec 22
Entry into a Material Definitive Agreement
9:18am
DEFA14A
zwxs0uo7sr
12 Dec 22
Additional proxy soliciting materials
10:41am
8-K
EX-99.1
uj0 4bp0zkb9l8h
8 Nov 22
Entry into a Material Definitive Agreement
9:15am